| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9402487 | Journal of Surgical Research | 2005 | 5 Pages |
Abstract
Lung cancer cells appear to respond to VES, albeit incompletely. Because tumor cell response is seen, lung cancer patients may derive some benefit from VES and should be considered in eventual clinical studies using this vitamin E derivative.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Jacquelyn M.D., Deborah M.S., Abigail B.A., Elizabeth M.D., Anthony P.A.C., Theresa R.N., M.S.N., Stephen M.D.,